Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Net Cash Flow (2018 - 2024)

Avai Bio's Net Cash Flow history spans 6 years, with the latest figure at -$615.0 for Q1 2024.

  • For Q1 2024, Net Cash Flow fell 100.69% year-over-year to -$615.0; the TTM value through Mar 2024 reached -$107191.0, down 244.5%, while the annual FY2025 figure was $80772.0, 175.35% up from the prior year.
  • Net Cash Flow for Q1 2024 was -$615.0 at Avai Bio, down from -$584.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $88660.0 in Q1 2023 and bottomed at -$106954.0 in Q2 2023.
  • The 4-year median for Net Cash Flow is $189.0 (2023), against an average of -$2068.1.
  • The largest YoY upside for Net Cash Flow was 209.08% in 2020 against a maximum downside of 10666.42% in 2020.
  • A 4-year view of Net Cash Flow shows it stood at -$14476.0 in 2020, then surged by 203.07% to $14921.0 in 2022, then plummeted by 103.91% to -$584.0 in 2023, then decreased by 5.31% to -$615.0 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Net Cash Flow are -$615.0 (Q1 2024), -$584.0 (Q4 2023), and $962.0 (Q3 2023).